not tagged
not tagged
['leusm', '#mpn', 'mpnsm', 'cml']
#asco22 #mpnsm #leusm attalah: in the end 70-80% of cml pts require lifelong therapy with current agents. cost savings to health system still significant. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)